The Watson Perspective

Your daily briefing on the innovation and intelligence reshaping the way we work.

JW
Editor
Joyce Watson

About This Column

Known for her ability to "illuminate the business implications" of complex change, Joyce Watson brings an analytical rigor to a new, expansive beat. Transitioning from her deep dive into AI and automation, Joyce now explores a wide array of topics that define the future of work - from the evolution of sales and marketing to the transformation of leadership in a digital age. She specializes in identifying the practical benefits and hidden pitfalls of emerging trends, providing actionable intelligence for leaders who want to build more resilient and innovative organizations.

Displaying items 161-180 of 768 in total

Niel's Gambit: Can Europe's Telecom Maverick Revitalize Vodafone?

Read full article
BriefGlance

Beyond the Top Spot: Navigating Business in Google's Zero-Click Era

Read full article
Beyond the Top Spot: Navigating Business in Google's Zero-Click Era

Opus One's Winemaker Retires: The End of an Era and a New Chapter

Read full article
Opus One's Winemaker Retires: The End of an Era and a New Chapter

The OR Efficiency Race: A New Tendon Aims to Reshape ACL Surgery

Read full article
The OR Efficiency Race: A New Tendon Aims to Reshape ACL Surgery

Miri's New Platform Puts Businesses in the Driver's Seat for Global Data

Read full article
Miri's New Platform Puts Businesses in the Driver's Seat for Global Data

Beyond the Scale: India's New War on Obesity and Its Corporate Playbook

Read full article
Beyond the Scale: India's New War on Obesity and Its Corporate Playbook

Decent's Big Pivot: From Wastewater to High-Tech Elder Care in China

Read full article
Decent's Big Pivot: From Wastewater to High-Tech Elder Care in China

QpiAI's Open SDK: A Quantum Leap for India and Global Developers

Read full article
QpiAI's Open SDK: A Quantum Leap for India and Global Developers

Stem Cell Therapy for Knees Enters US Trial, Hinting at a New FDA Path

Read full article
Stem Cell Therapy for Knees Enters US Trial, Hinting at a New FDA Path

51Talk Blends AI and Human Touch to Forge its Next Generation of Speakers

Read full article
51Talk Blends AI and Human Touch to Forge its Next Generation of Speakers

I Squared's Big Bet on the 'Dirty' Work of Clean Energy Production

Read full article
I Squared's Big Bet on the 'Dirty' Work of Clean Energy Production

The 15-Minute Fix: A Tulsa Firm's Bid to Reshape Pipeline Repair

Read full article
The 15-Minute Fix: A Tulsa Firm's Bid to Reshape Pipeline Repair

From Orchard Waste to Beverage Gold: A Strategic Blend of Profit & Purpose

Read full article
From Orchard Waste to Beverage Gold: A Strategic Blend of Profit & Purpose

Beyond the Tape: KT’s Bid to Conquer the Mainstream Pain Relief Market

Read full article
Beyond the Tape: KT’s Bid to Conquer the Mainstream Pain Relief Market

The Untethered Developer: Agent Approve Reins In Autonomous AI

Read full article
The Untethered Developer: Agent Approve Reins In Autonomous AI

Cambria County's Transit Leap: Data, Not Just Fares, Drives the Future

Read full article
Cambria County's Transit Leap: Data, Not Just Fares, Drives the Future

Beyond the Brand: The Academy Fixing Franchising's Hidden Weakness

Read full article
Beyond the Brand: The Academy Fixing Franchising's Hidden Weakness

The End of Emergency: PEMGARDA's Race for FDA Approval Begins

Read full article
The End of Emergency: PEMGARDA's Race for FDA Approval Begins

SynergenX's Patriotic TRT Deal: Healthcare Access or a Clever Sales Funnel?

Read full article
SynergenX's Patriotic TRT Deal: Healthcare Access or a Clever Sales Funnel?

LA's Rebuilding Limbo: A Systemic Failure and a Warning for Leaders

Read full article
LA's Rebuilding Limbo: A Systemic Failure and a Warning for Leaders
UCID: 29